127 related articles for article (PubMed ID: 34719977)
1. SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis.
Yuan D; Wang J; Yan M; Xu Y
Int J Biol Markers; 2021 Dec; 36(4):45-53. PubMed ID: 34719977
[TBL] [Abstract][Full Text] [Related]
2. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
Tang K; Liu J; Liu B; Meng C; Liao J
Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
[TBL] [Abstract][Full Text] [Related]
3. [Expression of SOX2 in cervical intraepithelial neoplasia and cervical cancer and its clinical significance].
Cai CF; Tan GS; Yu Q; Luan F; Yu L; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):128-30. PubMed ID: 25613627
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM
BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028
[TBL] [Abstract][Full Text] [Related]
5. [Expression of SOX2 in cervical intraepithelial neoplasia and cervical cancer and its clinical significance].
Cai C; Tan G; Yu Q; Luan F; Yu L; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):128-30. PubMed ID: 23353172
[TBL] [Abstract][Full Text] [Related]
6. The Clinical and Molecular Characteristics of Sex-Determining Region Y-Box 2 and its Prognostic Value in Breast Cancer: A Systematic Meta-Analysis.
Zhao G; Wang X; Qu L; Zhu Z; Hong J; Hou H; Li Z; Wang J; Lv Z
Breast Care (Basel); 2021 Feb; 16(1):16-26. PubMed ID: 33716628
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
Fahmi MN; Hertapanndika IN; Kusuma F
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
[TBL] [Abstract][Full Text] [Related]
8. [Expression of metastasis tumor-associated protein 2 in cervical squamous carcinoma and
its relationship with prognosis].
Xiao L; Huang S; Cheng H; Chen J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1031-1038. PubMed ID: 27807324
[TBL] [Abstract][Full Text] [Related]
9. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
10. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Survival Impact of Sex-Determining Region Y-Box 2 in Colorectal Cancer: An Integrated Analysis of the Immunohistochemical Study and Bioinformatics Analysis.
Song K; Hao J; Ge Z; Chen P
J Oncol; 2020; 2020():3761535. PubMed ID: 32104175
[TBL] [Abstract][Full Text] [Related]
12. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.
Yang F; Gao Y; Geng J; Qu D; Han Q; Qi J; Chen G
Int J Clin Exp Pathol; 2013; 6(12):2846-54. PubMed ID: 24294370
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
16. SOX2 como posible biomarcador pronóstico y diana molecular en el cáncer de pulmón: metaanálisis.
Zang K; Yu ZH; Wang M; Huang Y; Zhu XX; Yao B
Rev Clin Esp (Barc); 2022 Dec; 222(10):584-592. PubMed ID: 35941044
[TBL] [Abstract][Full Text] [Related]
17. The association of SOX2 with clinical features and prognosis in colorectal cancer: A meta-analysis.
Zhang XH; Wang W; Wang YQ; Zhu L; Ma L
Pathol Res Pract; 2020 Jan; 216(1):152769. PubMed ID: 31810585
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
Meng Y; Liu YL; Li K; Fu T
Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974
[TBL] [Abstract][Full Text] [Related]
19. SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix.
Stewart CJ; Crook M
Int J Gynecol Pathol; 2016 Nov; 35(6):566-573. PubMed ID: 26886477
[TBL] [Abstract][Full Text] [Related]
20. SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.
Russo MV; Esposito S; Tupone MG; Manzoli L; Airoldi I; Pompa P; Cindolo L; Schips L; Sorrentino C; Di Carlo E
Oncotarget; 2016 Mar; 7(11):12372-85. PubMed ID: 26540632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
